Medistim ASA (MEDI.OL) Stock Analysis & Winston Score
Medistim is a Norwegian medical device company that makes specialized tools used by heart surgeons during operations. Its main products are ultrasound-based systems that help surgeons check blood flow in real time while performing bypass and heart valve surgeries. The company sells primarily to hospitals and cardiac surgery centers, and it is one of the few companies in the world focused specifically on this narrow but critical niche of intraoperative blood flow measurement. Medistim makes money by selling its hardware systems to hospitals and then generating recurring revenue from disposable probes and software that surgeons use during each procedure. The company operates globally, with a strong presence in Europe and growing sales in North America and Asia, and its deep specialization in a technically demanding field gives it a durable competitive position with limited direct rivals. The key growth driver is the gradual expansion of cardiac surgery volumes worldwide, though its small size and dependence on a narrow product category mean any slowdown in hospital capital spending could meaningfully pressure results.
Winston Score: 77/100 — Strong
A high-quality business with solid fundamentals.
- Quality: Strong (24/30)
- Growth: Strong (16/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (9/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: 246.00 NOK
Market Cap: 4.5B NOK
Sector: Healthcare
Industry: Medical - Devices
Exchange: Oslo Stock Exchange

